These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1173117)

  • 1. Hyperlipoproteinemia in occlusive cerebrovascular disease.
    Mathew NT; Davis D; Meyer JS; Chandar K
    JAMA; 1975 Apr; 232(3):262-6. PubMed ID: 1173117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlipoproteinemia and cerebral strokes.
    Dekaban AS; Steusing JK; Stevens H
    Can J Neurol Sci; 1977 Feb; 4(1):13-7. PubMed ID: 837259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stroke - the role of hyperlipoproteinemia. I. Lipid metabolism and various arteriosclerosis risk factors in a control group].
    Hulanicka K; Piechocki DW; Guzowski K
    Neurol Neurochir Pol; 1981; 15(4):453-57. PubMed ID: 7329510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of plasma lipids and lipoprotein concentration to cerebral atherosclerosis and electrocardiographic findings.
    Ballantyne D; Grossart KW; Ballantyne JP; Young A; Lawrie TD
    J Neurol Sci; 1974 Oct; 23(2):323-9. PubMed ID: 4427120
    [No Abstract]   [Full Text] [Related]  

  • 5. [Frequency of abnormal lipid values and of hyperlipoproteinaemia in in-patients of a general hospital (author's transl)].
    Schräpler P; Petrides P; Schmidt FH; el-Hamalawi J; Stork H
    Dtsch Med Wochenschr; 1974 Aug; 99(34):1682-6. PubMed ID: 4368141
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudo-Sjögren syndrome with hyperlipoproteinemia.
    Goldman JA; Julian EH
    JAMA; 1977 Apr; 237(15):1582-4. PubMed ID: 576655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early manifestations and investigation of cerebral arteriosclerosis.
    Gilroy J
    Practitioner; 1976 Jul; 217(1297):66-73. PubMed ID: 792862
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistics for the study of cerebrovascular insufficiency due to occlusive or stenotic lesions of the carotid artery. I].
    Tedeschi G; Signorelli CD; De Divitiis E
    Rass Int Clin Ter; 1971 May; 51(9):534-42. PubMed ID: 5088698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J; Sezille G; Dewailly P; Fruchart JC
    Diabete Metab; 1977 Sep; 3(3):159-64. PubMed ID: 199484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Distribution and risk factors of steno-occlusive lesions in patients with ischemic cerebrovascular disease].
    Li D; Wang ML; Li SM; Ling F
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1158-62. PubMed ID: 18844107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipoprotein(a): structure, metabolism and atherosclerotic disease].
    Postorino G; Altavilla R
    Minerva Med; 1992 Oct; 83(10):581-8. PubMed ID: 1461528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial type IV hyperlipoproteinemia.
    Schreibman PH; Wilson DE; Arky RA
    N Engl J Med; 1969 Oct; 281(18):981-5. PubMed ID: 5824739
    [No Abstract]   [Full Text] [Related]  

  • 13. Cerebrovascular arteriopathy (arteriosclerosis) and ischemic childhood stroke.
    Daniels SR; Bates S; Lukin RR; Benton C; Third J; Glueck CJ
    Stroke; 1982; 13(3):360-5. PubMed ID: 7080131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the relationship between diabetes, hyperlipoproteinemia and atheromatosis].
    Righetti A; Scherrer JR; Micheli H; Pometta D
    Schweiz Med Wochenschr; 1973 May; 103(18):668-73. PubMed ID: 4702987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral consequences of essential arterial hypertension, in relation to the stage and clinical form of the disease (hemodynamic study)].
    Hărăguş S; Mureşan IG; Vlaicu R; Butnaru M
    Med Interna (Bucur); 1970 Sep; 22(9):1033-44. PubMed ID: 5491372
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in serum lipoproteins in cerebrovascular disease (author's transl)].
    Bruck J; Fischer M; Tschabitscher H
    Wien Klin Wochenschr; 1981 Oct; 93(19):604-9. PubMed ID: 7324470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)].
    Mertz DP; Hohneck A
    Med Klin; 1975 Jul; 70(28-29):1209-13. PubMed ID: 170497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stroke - the role of hyperlipoproteinemia. II. Lipid metabolism in stroke patients].
    Hulanicka K; Piechocki DW; Guzowski K
    Neurol Neurochir Pol; 1981; 15(4):459-67. PubMed ID: 7329511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
    Millikan CH
    Trans Am Neurol Assoc; 1973; 98():206-18. PubMed ID: 4784937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.